Cytogel Pharma, LLC
Eric Lang currently serves as a member of the Management Board at Cytogel Pharma, LLC, and as Chief Medical Officer at Chromocell Therapeutics since May 2023. Previously, Eric held the position of Chief Medical Officer at Nevakar Inc. from September 2018 to May 2023 and at EnteraBio from January 2018 to September 2018. Eric's earlier experience includes roles as VP and Head of Clinical Development at Nevakar Inc. and VP at Covance Inc., where responsibilities encompassed leading clinical drug development initiatives. Eric holds an MD in Medicine from Ben Gurion University of the Negev.
This person is not in any teams
This person is not in any offices
Cytogel Pharma, LLC
1 followers
Cytogel Pharma is a biopharmaceutical development company that pursues strategic opportunities for pharmaceutical product development. The company focuses on acquiring promising early-stage programs that offer significant potential both as platform technologies and high-value product candidates. Milestone-defined investment of corporate resourcespermits the company to enhance product value for partnering or licensing while retaining optimal equity value for its investors. Cytogel is venture backed by Centripetal Capital Partners.Cytogel Pharma was founded in 2002 and is based in Darien, Connecticut.